Press release
Dasatinib Drugs Market Size Projected To Reach $1.99 Billion By 2034 With A Cagr Of 6.6%
Dasatinib Drugs
_x000D_
What Is the Projected Growth of the Dasatinib Drugs Market?_x000D_
The dasatinib drugs market has expanded significantly, expected to grow from $1.45 billion in 2024 to $1.55 billion in 2025 at a CAGR of 6.9%. Market expansion is driven by the increasing prevalence of chronic myeloid leukemia (CML), growth in targeted cancer therapies, advancements in tyrosine kinase inhibitor (TKI) research, increased investment in oncology research, and rising clinical trials._x000D_
_x000D_
The dasatinib drugs market size is expected to expand significantly, reaching $2 billion by 2029 at a CAGR of 6.6%. Growth will be supported by increased investment in oncology drug pipelines, the rising prevalence of drug-resistant leukemia cases, the growing availability of generic dasatinib drugs, efforts to minimize chemotherapy side effects, and greater awareness and early diagnosis of leukemia. Major trends expected in this period include the adoption of personalized medicine, the implementation of companion diagnostics, the development of new formulations, advancements in combination therapies, and the rise of biosimilars._x000D_
_x000D_
Purchase the full report for exclusive industry analysis:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19023_x000D_
_x000D_
What Are the Different Dasatinib Drugs Market Segments?_x000D_
The dasatinib drugsmarket covered in this report is segmented -_x000D_
_x000D_
1) By Product Type: Tablets, Oral Suspension, Other Products_x000D_
2) By Indication: Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Other Indications_x000D_
3) By End User: Hospitals, Specialty Clinics, Home Healthcare_x000D_
_x000D_
Subsegments:_x000D_
1) By Tablets: 20 mg Tablets, 50 mg Tablets, 70 mg Tablets, 80 mg Tablets_x000D_
2) By Oral Suspension: 20 mg Or 5 mL Oral Suspension, 40 mg Or 5 mL Oral Suspension_x000D_
3) By Other Products: Injectable Formulations, Combination Therapies, Generic Dasatinib Products_x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=19023&type=smp_x000D_
_x000D_
What Are the Primary Drivers Shaping the Dasatinib Drugs Market?_x000D_
The growing incidence of chronic myeloid leukemia (CML) is anticipated to drive the expansion of the dasatinib drug market in the future. Chronic myeloid leukemia (CML) is a form of cancer that affects both the bone marrow and blood, characterized by the abnormal growth of white blood cells. The rising incidence of CML is primarily influenced by factors such as lifestyle choices, unhealthy eating habits, and escalating environmental risks. Dasatinib drugs are effective in treating CML by targeting BCR-ABL (gene fusion), a tyrosine kinase protein produced due to the Philadelphia chromosome mutation, which accelerates the uncontrolled growth of malignant white blood cells. For example, in January 2023, the American Cancer Society (ACS), a U.S.-based health organization, reported a rise in CML cases to 8,930, up from 8,860 in 2022 in the U.S. Thus, the growing prevalence of CML is fueling the demand for dasatinib drugs._x000D_
_x000D_
Which Companies Are Leading in the Dasatinib Drugs Market?_x000D_
Major companies operating in the dasatinib drugs market are Bristol-Myers Squibb Company, AstraZeneca plc, Novartis AG, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Sandoz Group AG, Hetero Drugs Limited, Sun Pharmaceutical Industries Limited, MSN Laboratories Pvt. Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, Intas Pharmaceuticals Ltd., Cipla Limited, Hikma Pharmaceuticals plc, Lupin Limited, Zhejiang Hisun Pharmaceutical Co. Ltd., Biocon Limited, Alkem Laboratories Limited, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals Limited, Alembic Pharmaceuticals Limited, Mylan N.V., Manus Aktteva Biopharma LLP_x000D_
_x000D_
What Trends Are Expected to Dominate the Dasatinib Drugs Market in the Next 5 Years?_x000D_
In the dasatinib drugs market, companies are focusing on generic drugs to increase market accessibility and provide affordable treatment options. In September 2024, Apotex Corp. launched the first generic version of Sprycel (dasatinib) in the United States, making it more accessible for patients and increasing competition in the leukemia treatment market._x000D_
_x000D_
Get the full report for exclusive industry analysis:_x000D_
https://www.thebusinessresearchcompany.com/report/dasatinib-drugs-global-market-report_x000D_
_x000D_
What Are the Top Revenue-Generating Geographies in the Dasatinib Drugs Market?_x000D_
North America was the largest region in the dasatinib drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dasatinib drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
Frequently Asked Questions:_x000D_
1. What Is the Market Size and Growth Rate of the Dasatinib Drugs Market?_x000D_
2. What is the CAGR expected in the Dasatinib Drugs Market?_x000D_
3. What Are the Key Innovations Transforming the Dasatinib Drugs Industry?_x000D_
4. Which Region Is Leading the Dasatinib Drugs Market?_x000D_
_x000D_
Why This Report Matters:_x000D_
_x000D_
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors._x000D_
_x000D_
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends._x000D_
_x000D_
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dasatinib Drugs Market Size Projected To Reach $1.99 Billion By 2034 With A Cagr Of 6.6% here
News-ID: 4048678 • Views: …
More Releases from The Business Research Company
Top Trends Transforming the Fluoropolymer Films Market Landscape in 2025: Techno …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Fluoropolymer Films Industry Market Size Be by 2025?
The fluoropolymer films market has seen strong growth recently. It will expand from $2.5 billion in 2024 to $2.65 billion in 2025 at a CAGR of 5.7%. Growth drivers in the past included high thermal stability, electronics manufacturing…
Driving Digitally Printed Wallpaper Market Growth in 2025: The Role of Rising Ur …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Digitally Printed Wallpaper Market Size Growth Forecast: What to Expect by 2025?
The digitally printed wallpaper market has expanded rapidly in recent years. It will grow from $9.13 billion in 2024 to $10.26 billion in 2025, at a CAGR of 12.4%. Historic growth was fueled by interior design preferences,…
Top Market Shifts Transforming the Biodegradable Paper and Plastic Packaging Mar …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Biodegradable Paper and Plastic Packaging Market Through 2025?
Over the past few years, we've witnessed a significant expansion in the size of the biodegradable paper and plastic packaging market. It is projected to rise from $12.97 billion in 2024 to $14.12 billion…
Acrylic Rubber Market Landscape to 2034: Key Forces Shaping the Next Decade of G …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Acrylic Rubber Market Size By 2025?
The acrylic rubber industry has seen robust growth in the past few years. The market value, which is projected to escalate from $1.63 billion in 2024 to $1.74 billion in 2025, implies a compound annual growth rate (CAGR) of…
More Releases for Dasatinib
Rising Prevalence Of Chronic Myeloid Leukemia (CML) Fuels Growth Of Dasatinib Dr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Dasatinib Drugs Industry Market Size Be by 2025?
The market for dasatinib drugs has seen robust growth lately. It's projected that the market will expand from $1.45 billion in 2024 to $1.55 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%. This growth…
Dasatinib Tablets Market Outlook and Future Projections for 2030
The dasatinib tablets market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the current…
Rising Prevalence Of Chronic Myeloid Leukemia (CML) Fuels Growth Of Dasatinib Dr …
What industry-specific factors are fueling the growth of the dasatinib drugs market?
The growing incidence of chronic myeloid leukemia (CML) is anticipated to drive the expansion of the dasatinib drug market in the future. Chronic myeloid leukemia (CML) is a form of cancer that affects both the bone marrow and blood, characterized by the abnormal growth of white blood cells. The rising incidence of CML is primarily influenced by factors such…
Emerging Dasatinib Drugs Market Trend 2025-2034: Generic Dasatinib Boosting Comp …
How Is the Dasatinib Drugs Market Projected to Grow, and What Is Its Market Size?
There has been a robust expansion in the market size of dasatinib drugs in the past few years. The market is projected to escalate from a worth of $1.45 billion in 2024 to $1.55 billion in 2025 with a compound annual growth rate (CAGR) of 6.9%. The factors that have contributed to market growth during the…
Dasatinib Tablets Market Outlook and Future Projections for 2030
The dasatinib tablets market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the current…
Dasatinib Drugs Market to Grow Significantly by Leading Players 2023 to 2032
The competitive landscape analysis of Dasatinib Drugs Market uncovers detailed company profiles, revenue shares, portfolio innovations, regional product footprint, key developmental strategies, pricing structure, target markets, and near-term plans of market leaders. This entire section helps readers gain an essence of what is driving competition and what would help them stand out to win new target markets.
Market estimates and forecast are backed by an extensive primary research, further complemented by…
